Ototoxic medication
checker

Method notes

What ototoxic means

Ototoxic means that a substance can affect structures involved in hearing or balance. The inner ear contains sensory organs for hearing and balance, and some medicines can affect those organs. Reported effects include hearing change, tinnitus, and balance problems. The word describes a possible effect associated with a medicine. It does not say that a person taking the medicine has damage, and it does not predict what will happen for one prescription.

This page is a read-only lookup over six documented groups: aminoglycoside antibiotics, platinum chemotherapy, loop diuretics, high-dose salicylates, quinine, and some macrolide antibiotics. The groups and common names are drawn from the cited ASHA information sheet, PubMed review, and NCBI review. The list is not complete. More than one source notes that many medicines and combinations can have auditory or balance effects, and some reports are rare or dependent on context.

The safest use of a lookup is to turn a vague worry into a specific question. Tell the prescriber the exact medicine, dose, route, start date, recent changes, other medicines, kidney or liver problems, and the first date of any hearing, tinnitus, or balance symptom. Do not make a medication change from a web list. The prescriber knows why the medicine was chosen and can weigh its intended role against possible adverse effects.

The documented classes

Aminoglycoside antibiotics

Aminoglycosides include amikacin, gentamicin, neomycin, streptomycin, and tobramycin. Ototoxicity references describe hearing effects, tinnitus, and balance effects for this group. ASHA identifies certain aminoglycosides among medicines associated with permanent damage. The exact concern can differ by medicine, dose, route, exposure time, and a person's susceptibility. Gentamicin is often discussed in relation to balance as well as hearing, while other agents are more strongly associated with cochlear effects.

Aminoglycosides are used for serious infections, so a list entry is not a reason to assume that a prescribed course is wrong. It is a reason to report a new change promptly and ask whether hearing or balance monitoring is appropriate. An audiologist can record a baseline or follow-up hearing profile when the care team considers that useful.

Platinum chemotherapy

Platinum chemotherapy includes cisplatin, carboplatin, and oxaliplatin in the reference list. Published reviews describe hearing effects, often with attention to high-frequency hearing. Tinnitus can also occur. The risk is influenced by the medicine and treatment plan, and the hearing change may not be obvious in everyday conversation at first.

For a person receiving cancer treatment, decisions belong with the oncology and prescribing team. A baseline hearing assessment can make later comparison easier when the team believes monitoring is needed. A new tinnitus or hearing change should be reported with its timing rather than interpreted through the list alone.

Loop diuretics

Loop diuretics include furosemide, bumetanide, ethacrynic acid, and torsemide. Reviews describe possible hearing effects, with context such as rapid administration, high exposure, kidney function, and use with other ototoxic medicines affecting concern. The effect may be temporary in some situations, but a web page cannot determine the course for an individual.

If a new hearing or tinnitus symptom begins during a loop diuretic course, record when it began and contact the prescriber. Ask whether an audiologist should assess hearing. Do not assume that the medicine is the cause, because illness, fluid balance, infection, noise exposure, and other medicines can also affect hearing or balance.

High-dose salicylates

Salicylates include aspirin and sodium salicylate. This page labels the group high-dose salicylates because the reference material discusses dose and exposure rather than treating every aspirin use as the same. Tinnitus and hearing changes are the effect types listed here. ASHA describes salicylate effects as often temporary, but the right interpretation depends on the dose, reason for use, and the person's symptoms.

The lookup does not calculate a safe dose and does not review over-the-counter products. If aspirin or another salicylate is part of a prescribed plan, discuss a concern with the prescriber. A sudden hearing change, severe dizziness, or another red flag needs prompt clinical assessment regardless of the suspected medicine.

Quinine

Quinine is associated in clinical references with tinnitus, hearing effects, and sometimes balance symptoms. Quinine and related medicines can have different indications, formulations, and exposure patterns. The class card includes quinidine as a common related name in the fixed reference list, but a pharmacist or prescriber should confirm the exact medicine and reason for use.

A person who notices ringing, muffled hearing, dizziness, or imbalance during a quinine-related prescription should describe the timing to the prescriber. The list cannot distinguish a medicine effect from infection, pressure, noise injury, migraine, or an inner-ear disorder. An audiologist or otolaryngologist can assess the ear and hearing when the symptom needs specialist review.

Some macrolide antibiotics

Macrolides in this reference list include azithromycin, clarithromycin, and erythromycin. Published reviews have associated some macrolides with hearing change and tinnitus. The word some matters: an association in a review is not a prediction for every macrolide, every dose, or every person. The result card is a prompt to check the exact medicine and timing with the prescriber.

New symptoms can also reflect the illness for which an antibiotic was prescribed, a fever, dehydration, another medicine, or a separate ear condition. Keep the focus on the full timeline. If hearing changes suddenly or balance becomes difficult, seek prompt care rather than waiting for a web lookup to explain it.

Why the effect type matters

Hearing, tinnitus, and balance are related but different reports. Hearing change may show up as muffled speech, difficulty in noise, or a need to increase volume. Tinnitus may be ringing, buzzing, hissing, or another internal sound. Balance effects may feel like spinning, unsteadiness, visual motion, or difficulty walking. A medicine reference can name the effect types, but only an assessment can describe what is happening for one person.

Some medicines are described as more strongly linked with permanent effects, while others are often discussed as temporary or reversible. Those descriptions are population-level statements from the cited references. They are not a promise about an individual and should not be used to make an unsupervised medication decision. The timing and severity of symptoms guide the need for clinical review.

What to bring to the prescriber

Bring the medicine container or an accurate medication list. Include the generic name if you have it, the strength, how often you use it, the route, the start date, and any recent dose or schedule change. List other prescriptions, over-the-counter medicines, and supplements. Note whether symptoms affect one ear or both, whether tinnitus is constant or intermittent, and whether dizziness or balance change is present.

If possible, write down when the symptom began and what happened next. A simple timeline can show whether a hearing change started before the medicine, during exposure, after a dose change, or after an illness. A clinician can decide whether a hearing test, balance assessment, medicine review, or another examination is appropriate. The page cannot make that decision.

Limits of this lookup

The six cards are examples from documented classes, not a full medication database. A medicine absent from the cards is not automatically free of auditory or balance effects. A medicine present on a card is not automatically the cause of a symptom. Product names vary by country, and combination medicines can contain more than one active ingredient.

The cited sources use different levels of evidence and different terms for temporary, permanent, cochlear, vestibular, hearing, tinnitus, and balance effects. This page keeps the descriptions broad to avoid turning a class reference into a personal risk calculation. It does not provide a dose threshold, a monitoring schedule, or a medicine alternative.

This checker is not medical advice and not a diagnosis. Discuss a specific concern with the prescriber. An audiologist can measure hearing, and an otolaryngologist can review ear and balance symptoms. Seek prompt care for sudden hearing change, facial weakness, severe dizziness, or other severe symptoms.

Making the lookup useful

Search by the generic name when possible. A brand name may not appear even when its active ingredient is represented. If the medicine is a combination product, write down every active ingredient. A pharmacist can help identify the generic name and explain whether the same class is present in another product you use.

Describe the symptom in practical terms. Say whether speech sounds muffled, whether you need more volume, whether the sound is ringing or another noise, and whether balance is affected. Mention whether one ear or both ears are involved. The pattern, timing, and severity give the prescriber more information than a class label alone.

When an audiologist adds useful information

An audiologist can measure hearing across frequencies, compare ears, assess speech understanding, and document change over time. When balance symptoms are present, the care team may consider a balance assessment. A baseline record can be useful for some higher-concern medicine plans, but the prescriber and audiologist decide whether it fits the individual situation.

Bring the lookup result only as a question prompt. Bring the medicine list, dates, symptoms, and relevant health history as the main information. This keeps the discussion focused on the exact prescription rather than on a broad internet category.

Questions readers ask

Sources

• ASHA, Audiology Information Series: Ototoxic Medications.
• NCBI, Approach to hearing loss.
• PubMed, The pharmacology of ototoxic drugs.
• ASHA, Audiologic Management of Individuals Receiving Cochleotoxic Drug Therapy.